Aspects of the future of therapy for patients infected with a high viral load and interferon-resistant subtype of HCV.
Matsumoto
Akihiro
A
Kiyosawa
Kendo
K
D000998:Antiviral Agents / Q000627:therapeutic use*; D024882:Drug Resistance, Viral; D004358:Drug Therapy / Q000639:trends*; D016174:Hepacivirus / Q000187:drug effects*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D019562:Viral Load / Q000639:trends*
D000998:Antiviral Agents; D007372:Interferons